Business Combination and Backstop Agreement (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands											3 Months Ended			9 Months Ended
	Dec. 05, 2024	Dec. 04, 2024	Nov. 13, 2024	Mar. 04, 2024	Nov. 02, 2023	Oct. 02, 2023	Feb. 14, 2023	Feb. 13, 2023	Sep. 07, 2022	Aug. 31, 2022	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 03, 2024	May 31, 2024	Oct. 04, 2023	May 23, 2023
Business Acquisition [Line Items]
Common stock exercise price											$ 18.00			$ 18.00				$ 9.00
Share price						$ 2.50
Fixed maturity consideration description														At any time prior to the Maturity Date, and in accordance with the terms of the Backstop Agreement, the Backstop Parties may elect an Optional Early Termination to sell some or all of the Backstop Shares. If the Backstop Parties sell any shares prior to the Maturity Date, the pro-rata portion of the Prepayment amount is due back to the Company. As of September 30, 2023, the Backstop Parties had sold 143,261 Backstop Shares, for which the Company has received net proceeds of $1.4 million, after paying related fees to the Backstop Parties. Depending on the manner in which the Backstop Agreement is settled, the Company may never have access to the full Prepayment.
Maturity consideration																			$ 6,700
[custom:ResetPrice-0]						$ 8.00
Aggregate gross purchase price														$ 1,795
Sale of stock price per share																		$ 7.00
Loss on extinguishment of debts												$ (224)			$ (15,080)
Payments for underwriting expense														$ 3,200
Right to pay underwriting description														The Company has a right to pay up to fifty percent (50%) of the principal and interest due on this promissory note using the common stock of the Company at a price per share of $10.56. The remaining fifty percent (50%) of the principal and interest due on this promissory note must be paid in cash.
Outstanding interest expense											$ 100	$ 100		$ 400	$ 200
Subsequent Event [Member]
Business Acquisition [Line Items]
Common stock exercise price																$ 1
Aggregate gross purchase price	$ 35,000	$ 35,000
Subsequent Event [Member] | Promissory Notes [Member]
Business Acquisition [Line Items]
Promissory note unpaid principal			$ 1,600
Promissory note, unpaid interest			500
Promissory note default amount			$ 2,100
Restricted Stock [Member]
Business Acquisition [Line Items]
Number of shares issued				169,582
Short-term loan amount				$ 1,600
Conversion price				$ 10.56
Promissory note unpaid principal				$ 1,600
Promissory note, unpaid interest				$ 200
Aesther Healthcare Acquisition Corp [Member]
Business Acquisition [Line Items]
Short-term loan amount																	$ 2,100
Maximum [Member]
Business Acquisition [Line Items]
Debt interest rate percentage											9.00%			9.00%
Debt instrument interest rate effective percentage											24.00%			24.00%
Maximum [Member] | Sponsor [Member]
Business Acquisition [Line Items]
Other accrued interest rate											15.00%			15.00%
Minimum [Member] | Sponsor [Member]
Business Acquisition [Line Items]
Other accrued interest rate											8.00%			8.00%
Backstop Agreement [Member]
Business Acquisition [Line Items]
Number of shares issued							1,350,000							4,885,466
Number of purchase of shares														4,885,466
Backstop Agreement [Member] | Maximum [Member]
Business Acquisition [Line Items]
Number of purchase of shares														8,000,000
Common stock exercise price											$ 10.56			$ 10.56
Meteora Agreement [Member]
Business Acquisition [Line Items]
Number of shares issued						2,667,667		2,666,667
Maturity Consideration [Member]
Business Acquisition [Line Items]
Number of purchase of shares														8,000,000
Common stock exercise price											2.50			$ 2.50
Backstop Forward Purchase Agreement [Member]
Business Acquisition [Line Items]
Backstop forward purchase agreement, value							$ 37,300
Share price							$ 10.56
Payment to backstop parties for backstop forward purchase agreement							$ 51,600
Fixed Maturity Consideration [Member] | Maximum [Member]
Business Acquisition [Line Items]
Number of shares issued														8,000,000
Share price											$ 2.50			$ 2.50
Common Stock Purchase Agreement [Member]
Business Acquisition [Line Items]
Number of shares issued					41,677									75,000
Aggregate gross purchase price					$ 64				$ 75,000
Fair value issuance														$ 500
Commitment costs													$ 500
Business Combination Agreement [Member]
Business Acquisition [Line Items]
Number of shares issued														1,365,000
Common stock in exchange for extensions														200,000	200,000
Loss on extinguishment of debt															$ 1,200
Loss on extinguishment of debts															(13,600)
Interest expense															$ 36
Common Stock [Member]
Business Acquisition [Line Items]
Additional shares issued to sponsor															1,365,000
Warrants exercisable							511,712
Exercise price							$ 8.06
Number of shares issued														169,582
Aggregate gross purchase price
Common Stock [Member] | Polar Agreement [Member] | Maximum [Member]
Business Acquisition [Line Items]
Number of shares issued								8,000,000
Aesther Healthcare Acquisition Corp [Member]
Business Acquisition [Line Items]
Business acquisition description of acquired entity										a) in the event that the volume-weighted average price (the “VWAP”) of the Company’s common stock exceeds $15.00 per share for twenty (20) out of any thirty (30) consecutive trading days beginning on the Closing date until the 36-month anniversary of the Closing, the Legacy Ocean Stockholders shall be entitled to receive an additional 5,000,000 shares of the Company’s common stock, (b) in the event that the VWAP of the Company’s common stock exceeds $17.50 per share for twenty (20) out of any thirty (30) consecutive trading days beginning on the Closing date until the 36-month anniversary of the Closing, the Legacy Ocean Stockholders shall be entitled to receive an additional 7,000,000 shares of the Company’s common stock and (c) in the event that the VWAP of the Company’s common stock exceeds $20.00 per share for twenty (20) out of any thirty (30) consecutive trading days beginning on the Closing date until the 36-month anniversary of the Closing, the Legacy Ocean Stockholders shall be entitled to receive an additional 7,000,000 shares of the Company’s common stock. In addition, for each issuance of Earnout Shares, the Company will also issue to Sponsor an additional 1,000,000 shares of the Company’s common stock.
Long term debt fair value											$ 500			$ 500
Aesther Healthcare Acquisition Corp [Member] | Maximum [Member]
Business Acquisition [Line Items]
Number of shares issued										19,000,000
Aesther Healthcare Acquisition Corp [Member] | Backstop Forward Purchase Agreement [Member]
Business Acquisition [Line Items]
Backstop agreement, shares							3,535,466
Backstop forward purchase agreement, value							$ 14,300
Share price							$ 10.56
Additional backstop forward purchase agreement, shares							1,350,000
New Ocean Biomedical [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Warrants exercisable							102,342
Exercise price							$ 7.47
Vellar Backstop Agreement [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Purchase of common stock, shares										8,000,000
Purchase of common stock, value										$ 80,000
Common Class A [Member]
Business Acquisition [Line Items]
Backstop agreement, shares							23,355,432
Backstop forward purchase agreement, value							$ 233,600
Conversion of stock shares converted							3,535,466
Common Class A [Member] | Aesther Healthcare Acquisition Corp [Member]
Business Acquisition [Line Items]
Backstop forward purchase agreement, value							$ 12,700
Additional shares issued to sponsor							1,365,000
Purchase of common stock, shares							1,200,000
Common Class B [Member] | Aesther Healthcare Acquisition Corp [Member]
Business Acquisition [Line Items]
Conversion of stock shares converted							2,625,000
Common stock conversion basis							converted on a one-for-one basis into shares of AHAC’s Class A common stock